XTL BIOPHARMACEUTICALS LTD's ticker is XTLB and the CUSIP is 98386D307. A total of 7 filers reported holding XTL BIOPHARMACEUTICALS LTD in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $0 | – | 153 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Noked Capital LTD | 198,888 | $662,000 | 0.22% |
| Noked Israel Ltd | 198,888 | $662,000 | 0.22% |
| SteelPeak Wealth, LLC | 14,375 | $48,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| MORGAN STANLEY | 54,026 | $180,000 | 0.00% |
| Renaissance Technologies | 38,800 | $129,000 | 0.00% |
| UBS Group AG | 3,524 | $12,000 | 0.00% |